NFKB1 and breast adenocarcinoma: Furthermore, the anti-inflammatory effects of piceatannol have been reported in various cell lines, including human monocytes (KBM-5), lymphoid cells (Jurkat), breast adenocarcinoma cells (MCF-7), and epithelial cells (HeLa), where piceatannol partially or completely inhibited TNF-α-induced NF-κB activation [38].